COVID-19 Clinical Research Studies
AMR locations nationwide are currently conducting or will soon be conducting several COVID-19 investigational clinical research studies. As with all studies, some exclusions will apply. However, we will have multiple studies needing participants from all walks of life. Compensation will be available for time and travel.
At this time, there is no proven prevention vaccine so this would offer potential coverage and an opportunity to help advance science in developing a proven vaccine.
AMR – El Dorado: 316-600-5127
COVID-19 Investigational Vaccine (ages 16+) (Phase III)
AMR – Fort Myers: 239-936-4421
COVID-19 Investigational Vaccine Clinical Research Study (Phase III)
AMR – Kansas City: 816-943-0770
COVID-19 Investigational Vaccine Clinical Research Study (Phase I)
COVID-19 Investigational Vaccine Clinical Research Study (Phase II)
COVID-19 Investigational Vaccine Clinical Research Study (Phase III)
AMR – Knoxville: 865-305-3784
COVID-19 Investigational Vaccine Clinical Research Study (Phase I)
COVID-19 Investigational Vaccine Clinical Research Study (Phase III)
AMR – Las Vegas: 702-545-6840
COVID-19 Investigational Vaccine Clinical Research Study (Phase III)
AMR – Lexington: 859-264-8999
COVID-19 Investigational Vaccine Clinical Research Study (Phase I)
COVID-19 Investigational Vaccine Clinical Research Study (Phase III)
AMR – Miami: 305-445-5637
COVID-19 Investigational Vaccine Clinical Research Study (Phase III)
COVID-19 Investigational Treatment Clinical Research Study (Phase II)
COVID-19 Investigational Vaccine (ages 18+ and 5-17) (Phase III)
COVID-19 Investigational Vaccine (ages 16+) (Phase III)
AMR – Mobile: 251-414-1984
COVID-19 Investigational Vaccine Clinical Research Study (Phase III)
COVID-19 Investigational Vaccine (ages 16+) (Phase III)
AMR – Newton: 316-283-0828
COVID-19 Investigational Vaccine Clinical Research Study (Phase II)
COVID-19 Investigational Vaccine Clinical Research Study (Phase III)
AMR – Tempe: 602-759-7559
COVID-19 Investigational Vaccine Clinical Research Study (Phase III)
COVID-19 Investigational Vaccine (ages 16+) (Phase III)
AMR – Wichita East: 316-689-6609
COVID-19 Investigational Vaccine Clinical Research Study (Phase III)
Smoking Cessation Clinical Research Study (daily smokers 18+)
AMR locations nationwide are participating in ORCA-2, a multicenter, double-blinded, randomized, placebo-controlled phase III trial evaluating the efficacy and safety of cytisinicline in adult smokers. In this study, the sponsor, Achieve Life Sciences, wants to find out if utilizing cytisinicline can increase cigarette smoking abstinence. To qualify, participants must be male or female, ages 18+ who are currently daily smokers (averaging at least 10 cigarettes per day upon completing a 7-day screening smoking diary) and who intend to quit smoking. Other study requirements apply.
AMR – Kansas City: 816-943-0770
AMR – Knoxville: 865-305-3784
AMR – Miami: 305-445-5637
AMR – Mobile: 251-414-1984
AMR – New Orleans: 504-821-2273
AMR – Norfolk: 757-627-7446
AMR – Las Vegas: 702-545-6840
AMR – Lexington: 859-264-8999
AMR – Wichita East: 316-689-6609
Healthy Volunteer Clinical Research Studies
Without healthy volunteer participation, clinical research would not be possible. We appreciate your consideration and hope you are able to help us bring new medicines to life.
RSV Vaccine Clinical Research Study (healthy volunteers ages 60+)
This is an Investigational RSV Vaccine Clinical Research Study for healthy volunteers 60 years of age and older. Respiratory syncytial virus (RSV) causes infections of the lungs and respiratory tract. In adults and older, healthy children, RSV symptoms are mild and typically mimic the common cold.
AMR – El Dorado: 316-600-5127
AMR – Kansas City: 816-943-0770
AMR – Miami: 305-445-5637
Chikungunya Vaccine Clinical Research Study (healthy volunteers ages 18+)
Chikungunya is an infection caused by the Chikungunya virus (CHIKV). Chikungunya virus is spread to people by the bite of an infected mosquito. Outbreaks have occurred in countries in Africa, Asia, Europe and the Indian and Pacific Oceans. This Investigational Chikungunya Vaccine Clinical Research Study is an important part of preventing global pandemics.
AMR – El Dorado: 316-600-5127
AMR – Kansas City: 816-943-0770
AMR – Knoxville: 865-305-3784
AMR – Las Vegas: 702-545-6840
AMR – Lexington: 859-264-8999
AMR – Mobile: 251-414-1984
AMR – New Orleans: 504-821-2273
AMR – Newton: 316-283-0828
AMR – Norfolk: 757-627-7446
AMR – Tempe: 602-759-7559
AMR – Wichita East: 316-689-6652
Flu Vaccine Clinical Research Study (healthy volunteers 50+)
This Investigational Flu Vaccine Clinical Research Study is for healthy volunteers 50 years of age and older.
AMR – Kansas City: 816-943-0770
AMR – Lexington: 859-264-8999
AMR – Mobile: 251-414-1984
AMR – Newton: 316-283-0828
AMR – Tempe: 602-759-7559
AMR – Wichita East: 316-689-6652Norfolk
FEATURED BY SITE
AMR – Fort Myers
Congenital Adrenal Hyperplasia
AMR – Kansas City
Acid Reflux
AMR – Lexington
Dietary Supplement for Skin Infections
AMR – Mobile
Ebola Vaccine
AMR – Norfolk
Rosacea
AMR – Knoxville
Ebola Vaccine
AMR – New Orleans
High Blood Pressure
AMR – Newton
Pediatric Constipation
AMR – Wichita East
GERD
AMR – Wichita West
Endometriosis
AMR – El Dorado
Low Testosterone